Deery Sarah E, Soden Peter A, Zettervall Sara L, Shean Katie E, Bodewes Thomas C F, Pothof Alexander B, Lo Ruby C, Schermerhorn Marc L
Division of Vascular and Endovascular Surgery, Beth Israel Deaconess Medical Center, Boston, Mass; Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Mass.
Division of Vascular and Endovascular Surgery, Beth Israel Deaconess Medical Center, Boston, Mass.
J Vasc Surg. 2017 Apr;65(4):1006-1013. doi: 10.1016/j.jvs.2016.08.100. Epub 2016 Dec 13.
Medicare studies have shown increased perioperative mortality in women compared with men following endovascular and open abdominal aortic aneurysm (AAA) repair. However, a recent regional study of high-volume centers, adjusting for anatomy but limited in sample size, did not show sex to be predictive of worse outcomes. This study aimed to evaluate sex differences after intact AAA repair in a national clinical registry.
The targeted vascular module of the National Surgical Quality Improvement Program was queried to identify patients undergoing endovascular aneurysm repair (EVAR) or open repair for intact, infrarenal AAA from 2011 to 2014. Univariate analysis was performed using the Fisher exact test and Mann-Whitney test. Multivariable logistic regression was used to account for differences in comorbidities, aneurysm details, and operative characteristics.
We identified 6611 patients (19% women) who underwent intact AAA repair (87% EVAR; 83% women vs 88% men; P < .001). Women were older (median age, 76 vs 73 years; P < .001), had smaller aneurysms (median, 5.4 vs 5.5 cm; P < .001), and had more chronic obstructive pulmonary disease (22% vs 17%; P < .001). Among patients undergoing EVAR, women had longer operative times (median, 138 [interquartile range, 103-170] vs 131 [106-181] minutes; P < .01) and more often underwent renal (6.3% vs 4.1%; P < .01) and lower extremity (6.6% vs 3.8%; P < .01) revascularization. After open repair, women had shorter operative time (215 [177-304] vs 226 [165-264] minutes; P = .02), but women less frequently underwent lower extremity revascularization (3.1% vs 8.2%; P = .03). Thirty-day mortality was higher in women after EVAR (3.2% vs 1.2%; P < .001) and open repair (8.0% vs 4.0%; P = .04). After adjusting for repair type, age, aneurysm diameter, and comorbidities, female sex was independently associated with mortality (odds ratio [OR], 1.7; 95% confidence interval [CI], 1.1-2.6; P = .02) and major complications (OR, 1.4; CI, 1.1-1.7; P < .01) after intact AAA repair. However, after adjusting for aortic size index rather than for aortic diameter, the association between female sex and mortality (OR, 1.5; CI, 0.98-2.4; P = .06) and major complications (OR, 1.1; CI, 0.9-1.4; P = .24) was reduced.
Women were at higher risk for 30-day death and major complications after intact AAA repair. Some of this disparity may be explained by differences in aortic size index, which should be further evaluated to determine the ideal threshold for repair.
医疗保险研究表明,与男性相比,女性在接受血管内和开放性腹主动脉瘤(AAA)修复术后围手术期死亡率更高。然而,最近一项针对高容量中心的区域性研究,虽对解剖结构进行了调整,但样本量有限,并未显示性别是预后较差的预测因素。本研究旨在评估全国临床登记中完整AAA修复术后的性别差异。
查询国家外科质量改进计划的目标血管模块,以识别2011年至2014年期间接受血管内动脉瘤修复(EVAR)或开放性修复完整肾下腹主动脉瘤的患者。使用Fisher精确检验和Mann-Whitney检验进行单因素分析。多变量逻辑回归用于分析合并症、动脉瘤细节和手术特征的差异。
我们确定了6611例接受完整AAA修复的患者(19%为女性)(87%为EVAR;女性占83%,男性占88%;P <.001)。女性年龄更大(中位年龄,76岁对73岁;P <.001),动脉瘤更小(中位值,5.4对5.5 cm;P <.001),慢性阻塞性肺疾病更多(22%对17%;P <.001)。在接受EVAR的患者中,女性手术时间更长(中位值,138[四分位间距,103 - 170]对131[106 - 181]分钟;P <.01),更常进行肾脏(6.3%对4.1%;P <.01)和下肢(6.6%对3.8%;P <.01)血管重建。开放性修复后,女性手术时间较短(215[177 - 304]对226[165 - 264]分钟;P =.02),但女性进行下肢血管重建的频率较低(3.1%对8.2%;P =.03)。EVAR术后女性30天死亡率较高(3.2%对1.2%;P <.001),开放性修复后也是如此(8.0%对4.0%;P =.04)。在调整修复类型、年龄、动脉瘤直径和合并症后,女性性别与完整AAA修复术后的死亡率(比值比[OR],1.7;95%置信区间[CI],1.1 - 2.6;P =.02)和主要并发症(OR,1.4;CI,1.1 - 1.7;P <.01)独立相关。然而,在调整主动脉大小指数而非主动脉直径后,女性性别与死亡率(OR,1.5;CI,0.98 - 2.4;P =.06)和主要并发症(OR,1.1;CI,0.9 - 1.4;P =.24)之间的关联减弱。
完整AAA修复术后,女性30天死亡和主要并发症的风险更高。这种差异部分可能由主动脉大小指数的差异解释,应进一步评估以确定理想的修复阈值。